Cargando…

COVID-19: Further evidence of no transfusion transmission

Detalles Bibliográficos
Autores principales:	Luzzi, José Roberto, Navarro, Roberta, Dinardo, Carla Luana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539824/ https://www.ncbi.nlm.nih.gov/pubmed/33077347 http://dx.doi.org/10.1016/j.transci.2020.102961

Ejemplares similares

The active role of a blood center in outpacing the transfusion transmission of COVID-19
por: Raturi, Manish, et al.
Publicado: (2020)

Zika virus, blood donation and transfusion transmission risk
por: Joob, Beuy, et al.
Publicado: (2019)

Continue ACE inhibitors / ARB’S till further evidence in coronavirus disease 2019 (COVID-19)
por: Bansal, Sandeep, et al.
Publicado: (2020)

Transmission of psoriasis by allogeneic bone marrow transplantation and blood transfusion
por: Li, X, et al.
Publicado: (2015)

Impact of COVID-19 on blood donation and transfusion services at Lusaka provincial blood transfusion centre, Zambia
por: Kasanga, Maisa, et al.
Publicado: (2020)

Adding up the evidence: Trigger for prophylactic plasma transfusion
por: Raturi, Manish, et al.
Publicado: (2017)

COVID-19: Thinking about further mental and neurological disorders
por: Monteiro-Junior, Renato Sobral
Publicado: (2020)

Further evidence for naturally occurring anti Jk(a) antibodies
por: Shastry, Shamee, et al.
Publicado: (2015)

Risk for Transmission of Pandemic (H1N1) 2009 Virus by Blood Transfusion
por: Matsumoto, Chieko, et al.
Publicado: (2010)

Transfusion reaction to hyperimmune plasma in patients with severe COVID-19 infection()
por: Edroso Jarne, Paloma Eugenia, et al.
Publicado: (2021)

Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Farag, Youssef M.K.
Publicado: (2020)

Blood and platelet transfusion from a donor with presymptomatic Covid-19
por: Liapis, Konstantinos, et al.
Publicado: (2020)

Postpartum depression amidst COVID-19 pandemic: What further could be done?
por: Issac, Alwin, et al.
Publicado: (2021)

In Reply — Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Joyner, Michael. J., et al.
Publicado: (2020)

Thoughts on Scientific Evidence in the COVID-19 Era
por: Mugnai, Giacomo, et al.
Publicado: (2020)

Transfusion-transmissible infections among voluntary blood donors at Government Medical College Thiruvananthapuram, Kerala, India
por: Anjali, H., et al.
Publicado: (2012)

Seroprevalence of transfusion-transmissible infections among replacement and voluntary blood donors in a tertiary care hospital
por: Arora, Disha, et al.
Publicado: (2017)

Opportunities for preventing further endothelial dysfunction in pregnant COVID-19 patients with familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2022)

Unexpected increase of the compliance rate of transfusion requisition form after the COVID-19 outbreak
por: Yang, L., et al.
Publicado: (2021)

Significant decrease in the transfusion rates during the COVID-19 pandemic in the North East of Iran
por: Boroumand-Noughabi, S., et al.
Publicado: (2022)

Fragmented QRS Pattern in Patients with COVID-19: Further Insights into Its Temporal and Mechanistic Features
por: Taylan, Gökay, et al.
Publicado: (2022)

COVID-19convalescent plasma use in the oncology and geriatric patients: Ethical aspects in transfusion medicine
por: Bansal, N., et al.
Publicado: (2022)

Household transmission of COVID-19 in Oman
por: Awang, Hafizuddin
Publicado: (2021)

Fecal‐oral transmission of COVID‐19
por: Joob, Beuy, et al.
Publicado: (2020)

Quandary Surrounding COVID19 Transmission
por: Kalra, Amit, et al.
Publicado: (2020)

Decreased glucose-6-phosphate dehydrogenase levels in vitiligo patients: Further evidence of oxidative stress
por: Farahi-Jahromy, Amir, et al.
Publicado: (2014)

Confirmatory factor analysis of the general activities of daily living scale: further evidences of internal validity
por: de Paula, Jonas Jardim, et al.
Publicado: (2017)

A sellar presentation of a WNT-activated embryonal tumor: further evidence of an ectopic medulloblastoma
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

Toxoplasma and Blood Transfusion
por: KARIMI, Gharib, et al.
Publicado: (2014)

Efficacy of IL-6 antagonists in the treatment of COVID-19 patients: further randomized controlled trials are warranted
por: Panda, Aditya K., et al.
Publicado: (2021)

Further comment on articles pertaining to: “Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19”
por: Berbert, Anne
Publicado: (2021)

Student mental health in the midst of the COVID-19 pandemic: A call for further research and immediate solutions
por: Grubic, Nicholas, et al.
Publicado: (2020)

Burns from hair dye in recovered COVID-19 patients, a new presentation for further investigation
por: Abdelaty, Mohamed
Publicado: (2022)

Open Science to Address COVID-19: Sharing Data to Make Our Research Investment Go Further
por: Zariffa, Névine, et al.
Publicado: (2020)

Prevalence and trends of transfusion transmitted infections in a regional blood transfusion centre
por: Gupta, Richa, et al.
Publicado: (2011)

Reframing the problem of the fomite transmission of COVID-19
por: Marsalek, J.
Publicado: (2021)

Further evidence that far‐UVC for disinfection is unlikely to cause erythema or pre‐mutagenic DNA lesions in skin
por: Barnard, Isla Rose Mary, et al.
Publicado: (2020)

Further peer review failures
por: Rivera, Horacio
Publicado: (2011)

SBP block: further considerations
por: De Cassai, Alessandro, et al.
Publicado: (2019)

Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention
por: Kasperkiewicz, Michael
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vtg5gd1b04mqbtkjv6aoapecfl